FDG PET/CT beyond mismatch exclusion in [177Lu]Lu-PSMA therapy: baseline prognosis and response assessment
The EANM Journal
· Elsevier
Аннотация
Publication date: September 2026 Source: The EANM Journal, Volume 4 Author(s): Mutaz Kassas, Marc-André Léger, Raluca Poenaru, Djawida Tahmi, Rande Latif Zeiter, Qaid Ahmed Shagera, Younes Abadi, Ioannis Karfis, Patrick Flamen, Carlos Artigas
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Медицина»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
FDG PET/CT beyond mismatch exclusion in [177Lu]Lu-PSMA therapy: baseline prognosis and response assessment. // The EANM Journal. – URL: https://www.sciencedirect.com/science/article/pii/S3051292126002186?dgcid=rss_sd_all
FDG PET/CT beyond mismatch exclusion in [177Lu]Lu-PSMA therapy: baseline prognosis and response assessment. The EANM Journal. https://www.sciencedirect.com/science/article/pii/S3051292126002186?dgcid=rss_sd_all
“FDG PET/CT beyond mismatch exclusion in [177Lu]Lu-PSMA therapy: baseline prognosis and response assessment.” The EANM Journal.
@article{article67782,
title = {FDG PET/CT beyond mismatch exclusion in [177Lu]Lu-PSMA therapy: baseline prognosis and response assessment},
journal = {The EANM Journal},
url = {https://www.sciencedirect.com/science/article/pii/S3051292126002186?dgcid=rss_sd_all}
}